These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9800495)

  • 1. [Monitoring of oral anticoagulant therapy in Norway--recommendations for transfer to the INR system].
    Sandset PM
    Tidsskr Nor Laegeforen; 1998 Sep; 118(22):3443-5. PubMed ID: 9800495
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral anticoagulant initiation: rationale for the use of warfarin dosing nomograms.
    Crowther MA
    Semin Vasc Med; 2003 Aug; 3(3):255-60. PubMed ID: 15199458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishing an oral anticoagulant monitoring service in a multiethnic developing country.
    Casimire T; Carter R; Peters S; Tweedle J; Charles KS
    Int J Lab Hematol; 2008 Dec; 30(6):531-5. PubMed ID: 18983306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of oral anticoagulant treatment in patients with venous thromboembolism.
    Pengo V
    Semin Thromb Hemost; 2006 Nov; 32(8):781-6. PubMed ID: 17171590
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment in point-of-care coagulation testing.
    Kitchen DP; Kitchen S; Jennings I; Woods T; Walker I
    Semin Thromb Hemost; 2008 Oct; 34(7):647-53. PubMed ID: 19085765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of the CoaguChek XS for point-of-care international normalized ratio (INR) measurement in children requiring warfarin.
    Bauman ME; Black KL; Massicotte MP; Bauman ML; Kuhle S; Howlett-Clyne S; Cembrowski GS; Bajzar L
    Thromb Haemost; 2008 Jun; 99(6):1097-103. PubMed ID: 18521514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of a new small-volume coagulation monitor: the SmartCheck INR system.
    Gardiner C; Longair I; Hills J; Cohen H; Mackie IJ; Machin SJ
    Am J Clin Pathol; 2008 Mar; 129(3):500-4. PubMed ID: 18285276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recommended use of INR in the laboratory monitoring of oral anticoagulant treatment].
    Syrjälä M
    Duodecim; 1998; 114(6):573-5. PubMed ID: 11466922
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral anticoagulant monitoring by laboratory or near-patient testing: what a clinician should be aware of.
    Tripodi A; Breukink-Engbers WG; van den Besselaar AM
    Semin Vasc Med; 2003 Aug; 3(3):243-54. PubMed ID: 15199457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring oral anticoagulant therapy--INR values for the Owren prothrombin time.
    Jackson CM
    Thromb Haemost; 2004 Feb; 91(2):210-2. PubMed ID: 14961145
    [No Abstract]   [Full Text] [Related]  

  • 13. The International Normalized Ratio (INR): a review.
    Then KL; Rankin JA
    Can J Cardiovasc Nurs; 1999; 10(1-2):40-2. PubMed ID: 10786468
    [No Abstract]   [Full Text] [Related]  

  • 14. [PT (INR) in extractive dental surgery in patients treated with oral anticoagulants].
    Caldarola F; Tealdi R; Molinatti M
    Minerva Stomatol; 1994 Apr; 43(4):167-9. PubMed ID: 8065287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Recommendation for the introduction of the International Normalized Ratio as an objective measure for the dosage of oral anticoagulant therapy].
    Horstkotte D; Hohnloser S; Keller F; Kolde HJ; Müller-Beissenhirtz W; Taborski U; Webering F
    Z Kardiol; 1994 Sep; 83(9):676-9. PubMed ID: 7801672
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality assurance for point-of-care testing of oral anticoagulation: a large-scale evaluation of the Hemochron Junior Signature Microcoagulation System.
    Maddox JM; Bogo PH; McGregor E; Pippard MJ; Kerr R
    Int J Lab Hematol; 2009 Apr; 31(2):142-50. PubMed ID: 18177437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral anticoagulant treatment].
    Melis Tormos E
    Rev Enferm; 2009 May; 32(5):48-54. PubMed ID: 19552155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of frozen plasma calibrants for enhanced standardization of the international normalized ratio (INR): a multi-center study.
    Adcock DM; Johnston M
    Thromb Haemost; 2002 Jan; 87(1):74-9. PubMed ID: 11848460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
    Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rebuttal to: strong lupus anticoagulant can influence the prothrombin time INR falsifying the follow up of oral anticoagulation.
    Bailleul E; Van Vaerenbergh K; Lust A
    Thromb Haemost; 2005 Sep; 94(3):687; author reply 688. PubMed ID: 16268495
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.